Evangeline Vassilatou

Dr. Evangeline Vassilatou

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in European Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
EVEvangeline Vassilatou
Evangeline Vassilatou
DVD A Vassiliadi
D A Vassiliadi
KSK Salambasis
K Salambasis
HLH Lazaridou
H Lazaridou
NKN Koutsomitopoulos
N Koutsomitopoulos
GDG Dimitriadis
G Dimitriadis
Objective: Limited data exist concerning the presence of polycystic ovary syndrome (PCOS) in premenopausal women with nonalcoholic fatty liver disease (NAFLD). We aimed to investigate the prevalence of PCOS in overweight and obese premenopausal women with NAFLD.Design: Prospective, observational, and cross-sectional study.Methods: We studied 110 apparently healthy, overweight, and obese (BMI: 25.1–49.1 kg/m2) premenopausal women (age: 18–45 years) reporting no or minimal alcohol consumption for NAFLD with abdominal ultrasonography after excluding causes of secondary liver disease and for PCOS (Rotterdam criteria) with clinical examination, biochemical evaluation, and pelvic ultrasonography. Insulin resistance (IR) was assessed by homeostasis model assessment of IR (HOMA-IR), and free androgen index was calculated.Results: NAFLD was detected in 71/110 women (64.5%). Women with NAFLD compared to women without NAFLD were more commonly diagnosed with PCOS (43.7% vs 23.1%, respectively,P=0.04), metabolic syndrome (30.2% vs 5.3%, respectively,P=0.003), and abnormal lipid profile (81.1% vs 51.3%,P=0.002). All women with abnormal glucose metabolism had NAFLD (P=0.01). Although PCOS was associated with NAFLD (OR 2.6, 95% CI: 1.1–6.2,P=0.04), in a multivariate analysis higher HOMA-IR values (OR 2.2, 95% CI: 1.1–4.4,P=0.02) and triglyceride levels (OR 1.01, 95% CI: 1.00–1.02,P=0.04) independently predicted NAFLD, after adjusting for age, BMI, and waist-to-hip ratio.Conclusions: These findings indicate an increased prevalence of PCOS in overweight and obese premenopausal women with NAFLD, although it is not supported that the syndrome is primarily involved in NAFLD. Evaluation for PCOS may be considered in these women.

1 October 2018 in Maturitas
Verified
Journal Article
Closed access
EVEvangeline Vassilatou
Evangeline Vassilatou
SLSophia Lafoyianni
Sophia Lafoyianni
DVDimitra Argyro Vassiliadi
Dimitra Argyro Vassiliadi
DIDimitrios Ioannidis
Dimitrios Ioannidis
SPStavroula A. Paschou
Stavroula A. Paschou
AVAndromachi Vryonidou
Andromachi Vryonidou

21 June 2016 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
EVEvangeline Vassilatou
Evangeline Vassilatou
EPE. Papadavid
E. Papadavid
PPP. Papastamatakis
P. Papastamatakis
DAD. Alexakos
D. Alexakos
DKD. Koumaki
D. Koumaki
DRD. Rigopoulos
D. Rigopoulos

10 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EVEleni Vrigkou
Eleni Vrigkou
EVEvangeline Vassilatou
Evangeline Vassilatou
EDEffrosyni Dima
Effrosyni Dima
DLDavid Langleben
David Langleben
Anastasia KotanidouAnastasia Kotanidou
Anastasia Kotanidou
MTMarinella Tzanela
Marinella Tzanela
Pulmonary hypertension (PH) is a progressive disorder characterized by a chronic in-crease in pulmonary arterial pressure, frequently resulting in right-sided heart failure and potentially death. Co-existing medical conditions are important factors in PH, since they not only result in the genesis of the disorder, but may also contribute to its progression. Various studies have assessed the impact of thyroid disorders and other endocrine conditions (namely estrogen exposure, obesity, and diabetes mellitus) on the progression of PH. The complex interactions that hormones may have with the cardiovascular system and pulmonary vascular bed can create several pathogenetic routes that could explain the effects of endocrine disorders on PH development and evolution. The aim of this review is to summarize current knowledge on the role of concomitant thyroid disorders, obesity, diabetes mellitus, and estrogen exposure as potential modifiers for PH, and especially for pulmonary arterial hypertension, and to discuss possible pathogenetic routes linking them with PH. This information could be valuable for practicing clinicians so as to better evaluate and/or treat concomitant endocrine conditions in the PH population.